Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: the first report.
Narumi Y, Yoshida R, Minami Y, Yamamoto Y, Takeguchi S, Kano K, Takahashi K, Saito T, Sawada J, Terui H, Katayama T, Sasaki T, Ohsaki Y.
Narumi Y, et al. Among authors: ohsaki y.
BMC Cancer. 2018 Jan 24;18(1):95. doi: 10.1186/s12885-018-3997-2.
BMC Cancer. 2018.
PMID: 29361915
Free PMC article.